Table 1. Clinical and demographic markers of SAVR subjects.
| marker | SAVR (n = 11) |
|---|---|
| Age [yrs] | 76 ± 5 |
| Gender [male] | 7 (64) |
| Weight [kg] | 72.5 ± 11.5 |
| BMI [kg·m-2] | 26.3 ± 3.9 |
| Congestive heart failure | 0 (0) |
| Recent myocardial infarction | 0 (0) |
| Previous cerebrovascular events | 0 (0) |
| LVEF [%] | 59.9 ± 7.0 |
| Diabetes | 1 (9) |
| COPD | 1 (9) |
| Serum creatinine [mg·dl-1] | 0.92 ± 0.19 |
| Hypertension | 9 (82) |
| HCT [%] | 40.6 ± 4.9 |
| ACE inhibitors | 7 (64) |
| Beta-blockers | 6 (55) |
| Diuretics | 4 (36) |
| Calcium antagonists | 2 (18) |
| Antiarrhythmic drugs | 0 (0) |
| Combined intervention | 8 (73) |
| EuroSCORE II | 3.0 ± 2.6 |
| CPB time [minutes] | 109.6 ± 43.3 |
| Nadir temperature on CPB [°C] | 33.6 ± 1.5 |
| Catecholamine administration | 3 (27) |
| Mechanical ventilation time [hours] | 11.2 ± 6.2 |
| ICU stay [days] | 2.1 ± 1.0 |
| Hospital stay [days] | 8.3 ± 3.8 |
| Postoperative atrial fibrillation | 6 (55) |
| Postoperative arrhythmias | 2 (18) |
| Postoperative low cardiac output syndrome | 2 (18) |
| Postoperative stroke | 0 (0) |
| Postoperative acute kidney injury | 0 (0) |
SAVR = surgical aortic valve replacement; BMI = body mass index; LVEF = left ventricular ejection fraction; COPD = chronic obstructive pulmonary disease; HCT = hematocrit; ACE = angiotensin converting enzyme; EuroSCORE = European System for Cardiac Operative Risk Evaluation; CPB = cardiopulmonary bypass; ICU = intensive care unit. Continuous data are presented as mean ± standard deviation and categorical data as number (percentage).